Ticker Details
VolitionRX Limited Common Stock VolitionRX Ltd is a clinical-stage life sciences company. The company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.
IPO Date:	April 1, 2012
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$15.97M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 3.87%
Avg Daily Range (30 D):	$0.09 | 5.09%
Avg Daily Range (90 D):	$0.08 | 5.56%

Institutional Daily Volume
Avg Daily Volume:	.03M
Avg Daily Volume (30 D):	.32M
Avg Daily Volume (90 D):	.52M

Trade Size
Avg Trade Size (Sh.):	44
Avg Trade Size (Sh.) (30 D):	155
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	12
Avg Institutional Trade:	$2.06M
Avg Institutional Trade (30 D):	$.68M
Avg Institutional Trade (90 D):	$.68M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.26M
Avg Closing Trade (30 D):	$.68M
Avg Closing Trade (90 D):	$.68M
Avg Closing Volume:	49.24K

News

May 27, 2026 @ 12:17 PM VolitionRx Highlights Commercial Momentum and Mult... Source: Prnewswire

Jan 3, 2024 @ 12:59 PM Why Trinity Place Holdings Shares Are Trading High... Source: Avi Kapoor

Nov 27, 2023 @ 11:26 AM IO Biotech And 2 Other Stocks Under $2 Insiders Ar... Source: Lisa Levin

Nov 20, 2023 @ 1:45 PM Ondas Holdings And 2 Other Stocks Under $1 Insider... Source: Lisa Levin

Oct 6, 2023 @ 12:26 PM Top 4 Health Care Stocks That Are Preparing To Pum... Source: Lisa Levin

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS
Diluted EPS		$-.97
Revenue	$2.47M	$.99M	$.45M
Gross Profit
Net Income / Loss	$-24.73M	$-6.7M	$-6.3M
Operating Income / Loss	$-21.57M	$-5.35M	$-4.82M
Cost of Revenue
Net Cash Flow	$.5M	$1.99M	$.92M
PE Ratio

Splits
Apr 28, 2026	1:20